Copper-Associated Liver Diseases

Veterinary Clinics of North America - Small Animal Practice

Volumn 39, Issue 3, 2009, Pages 489-511

  Hoffmann, Gaby ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Centro lobular copper; Diet; Heritability; Metabolic disease; Wilson's disease

Indexed keywords

COPPER; GLUCONATE ZINC; N,N' BIS(2 AMINOETHYL) 1,3 PROPANEDIAMINE; PENICILLAMINE; PLACEBO; PREDNISOLONE; TETRATHIOMOLYBDATE AMMONIUM; ZINC;

ANEMIA; AUTOIMMUNE DISEASE; BONE MARROW SUPPRESSION; CHELATION THERAPY; CHRONIC HEPATITIS; COPPER DEFICIENCY; COPPER METABOLISM; CYTOPENIA; DIET THERAPY; DOG DISEASE; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG FEVER; HEMOLYSIS; HUMAN; INTOXICATION; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LUPUS LIKE SYNDROME; LYMPHADENOPATHY; MENKES SYNDROME; NONHUMAN; OXIDATIVE STRESS; PROTEINURIA; QUANTITATIVE ANALYSIS; RECOMMENDED DRUG DOSE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXIC HEPATITIS; VITAMIN DEFICIENCY; WILSON DISEASE;

ANIMALS; CHOLESTASIS; COPPER; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; DRUG-INDUCED LIVER INJURY; HUMANS; LIVER DISEASES; METAL METABOLISM, INBORN ERRORS; MICE; RATS; SHEEP;

ANIMALIA;

EID: 67649406204     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2009.02.001     Document Type: Review

References (119)

1. Ferenci P., Zollner G., and Trauner M. Hepatic transport systems. J Gastroenterol Hepatol 17 Suppl (2002) S105-S112
2. Harris E.D. Cellular copper transport and metabolism. Annu Rev Nutr 20 (2000) 291-310
3. Sharp P.A. Ctr1 and its role in body copper homeostasis. Int J Biochem Cell Biol 35 (2003) 288-291
4. Cox D.W. Disorders of copper transport. Br Med Bull 55 (1999) 544-555
5. Failla M.L., Johnson M.A., and Prohaska J.R. Copper. In: Bowman B.A., and Russell R.M. (Eds). Present knowledge in nutrition. 8th edition (2001), ILSI Press, Washington, DC 373-383
6. Huffman D.L., and O'Halloran T.V. Function, structure, and mechanism of intracellular copper trafficking proteins. Annu Rev Biochem 70 (2001) 677-701
7. Huffman D.L., and O'Halloran T.V. Energetics of copper trafficking between the Atx1 metallochaperone and the intracellular copper transporter, Ccc2. J Biol Chem 275 (2000) 18611-18614
8. Prohaska J.R., and Gybina A.A. Intracellular copper transport in mammals. J Nutr 134 (2004) 1003-1006
9. Puig S., and Thiele D.J. Molecular mechanisms of copper uptake and distribution. Curr Opin Chem Biol 6 (2002) 171-180
10. Zentek J., Buhl R., Wolf, et al. [Unusual high frequency of liver cirrosis with copper storage in German sheperds]. der Praktische Tierarzt 80 3 (1999) 170-175 [in German]
11. Kastenmayer P., Czarnecki-Maulden G.L., and King W. Mineral and trace element absorption from dry dog food by dogs, determined using stable isotopes. J Nutr 132 (2002) 1670S-1672S
12. Prohaska J.R., and Brokate B. Copper deficiency alters rat dopamine beta-monooxygenase mRNA and activity. J Nutr 129 (1999) 2147-2153
13. Arnesano F., Banci L., Bertini I., et al. Metallochaperones and metal-transporting ATPases: a comparative analysis of sequences and structures. Genome Res 12 (2002) 255-271
14. Handy R.D., Eddy F.B., and Baines H. Sodium-dependent copper uptake across epithelia: a review of rationale with experimental evidence from gill and intestine. Biochim Biophys Acta 1566 (2002) 104-115
15. Danks D.M. Disorders of copper transport. In: Scriver C.R., Beaudet A.L., Sly W.S., et al. (Eds). The metabolic and molecular bases of inherited disease. 7th edition (1995), McGraw-Hill, New York 2211-2235
16. Zakim D., and Boyer T.D. Hepatology: a textbook of liver disease (2002), Elsevier Health Sciences, Philadelphia
17. Dick F.D., De Palma G., Ahmadi A., et al. Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study. Occup Environ Med 64 (2007) 673-680
18. Dong S.L., Cadamuro S.A., Fiorino F., et al. Copper binding and conformation of the N-terminal octarepeats of the prion protein in the presence of DPC micelles as membrane mimetic. Biopolymers 88 6 (2007) 840-847
19. Gaggelli E., Kozlowski H., Valensin D., et al. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem Rev 106 (2006) 1995-2044
20. Klevay L.M. Alzheimer's disease as copper deficiency. Med Hypotheses 70 4 (2007) 802-807
21. Leach S.P., Salman M.D., and Hamar D. Trace elements and prion diseases: a review of the interactions of copper, manganese and zinc with the prion protein. Anim Health Res Rev 7 (2006) 97-105
22. Haywood S., Simpson D.M., Ross G., et al. The greater susceptibility of North Ronaldsay sheep compared with Cambridge sheep to copper-induced oxidative stress, mitochondrial damage and hepatic stellate cell activation. J Comp Pathol 133 (2005) 114-127
23. vd Ingh V.W., Cullen V., Charles J., et al. Morphological classification of parenchymal disorders of the canine and feline liver. In: Rothuizen J., Bunch S., Charles J., et al. (Eds). WSAVA standards for clinical and histological diagnosis of canine and feline liver diseases (2006), Elsevier/Saunders, Philadelphia 85-101
24. Poffenbarger E.M., and Hardy R.M. Hepatic cirrhosis associated with long-term primidone therapy in a dog. J Am Vet Med Assoc 186 (1985) 978-980
25. van de Sluis B., Rothuizen J., Pearson P.L., et al. Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum Mol Genet 11 (2002) 165-173
26. Zudenigo D., and Relja M. [Hepatolenticular degeneration]. Neurologija 39 (1990) 115-127 [in Croatian]
27. Haywood S., Rutgers H.C., and Christian M.K. Hepatitis and copper accumulation in Skye terriers. Vet Pathol 25 (1988) 408-414
28. Hoffmann G., van den Ingh T.S., Bode P., et al. Copper-associated chronic hepatitis in Labrador retrievers. J Vet Intern Med 20 (2006) 856-861
29. Mandigers P.J., van den Ingh T.S., Bode P., et al. Association between liver copper concentration and subclinical hepatitis in Doberman pinschers. J Vet Intern Med 18 (2004) 647-650
30. Thornburg L.P., Shaw D., Dolan M., et al. Hereditary copper toxicosis in West Highland white terriers. Vet Pathol 23 (1986) 148-154
31. Twedt D.C., Sternlieb I., and Gilbertson S.R. Clinical, morphologic, and chemical studies on copper toxicosis of Bedlington Terriers. J Am Vet Med Assoc 175 (1979) 269-275
32. Webb C.B., Twedt D.C., and Meyer D.J. Copper-associated liver disease in Dalmatians: a review of 10 dogs (1998-2001). J Vet Intern Med 16 (2002) 665-668
33. Hoffmann G, Mesu S, Jones P, et al. Double blind placebo-controlled treatment with D-penicillamine against hepatic copper in Labrador retrievers. Presented at the American College of Veterinary Internal Medicine forum. Louisville, Kentucky, 2006.
34. Thornburg L.P., Rottinghaus G., McGowan M., et al. Hepatic copper concentrations in purebred and mixed-breed dogs. Vet Pathol 27 (1990) 81-88
35. Bravo A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500
36. Cole T.L., Center S.A., Flood S.N., et al. Diagnostic comparison of needle and wedge biopsy specimens of the liver in dogs and cats. J Am Vet Med Assoc 220 (2002) 1483-1490
37. Rawlings C.A., and Howerth E.W. Obtaining quality biopsies of the liver and kidney. J Am Anim Hosp Assoc 40 (2004) 352-358
38. Vasanjee S.C., Bubenik L.J., Hosgood G., et al. Evaluation of hemorrhage, sample size, and collateral damage for five hepatic biopsy methods in dogs. Vet Surg 35 (2006) 86-93
39. Wang K.Y., Panciera D.L., Al-Rukibat R.K., et al. Accuracy of ultrasound-guided fine-needle aspiration of the liver and cytologic findings in dogs and cats: 97 cases (1990-2000). J Am Vet Med Assoc 224 (2004) 75-78
40. Mufti A.R., Burstein E., and Duckett C.S. XIAP: cell death regulation meets copper homeostasis. Arch Biochem Biophys 463 (2007) 168-174
41. vd Ingh C., Twedt T., van Winkle R., et al. Morphological classification of biliary disorders of the canine and feline liver. In: Rothuizen J., Bunch S., Charles J., et al. (Eds). WSAVA standards for clinical and histological diagnosis of canine and feline liver diseases (2006), Saunders/Elsevier, Philadelphia 61-76
42. Spee B., Arends B., van den Ingh T.S., et al. Copper metabolism and oxidative stress in chronic inflammatory and cholestatic liver diseases in dogs. J Vet Intern Med 20 5 (2006) 1085-1092
43. Shehan H. Theory and practice of histotechnology. In: Sheehan D.C., and Hrapchak B.B. (Eds). Theory and practice of histotechnology. 2nd edition (1980), CV Mosby Co, St. Louis (MO) 230
44. Johnson G.F., Gilbertson S.R., Goldfischer S., et al. Cytochemical detection of inherited copper toxicosis of Bedlington terriers. Vet Pathol 21 (1984) 57-60
45. Spee B., Mandigers P.J., Arends B., et al. Differential expression of copper-associated and oxidative stress related proteins in a new variant of copper toxicosis in Doberman pinschers. Comp Hepatol 4 (2005) 3
46. van den Ingh T.S., Rothuizen J., and Cupery R. Chronic active hepatitis with cirrhosis in the Doberman pinscher. Vet Q 10 (1988) 84-89
47. Pilloni L., Lecca S., Van Eyken P., et al. Value of histochemical stains for copper in the diagnosis of Wilson's disease. Histopathology 33 (1998) 28-33
48. Hardy R.M., Stevens J.B., and Stowe C.M. Chronic progressive hepatitis in Bedlington terriers associated with elevated copper concentrations. Minn Vet 15 (1975) 13-24
49. Doige S.L. Chronic active hepatitis in dogs: a review of 14 cases. J Am Anim Hosp Assoc 17 5 (1981) 725-730
50. Fuentealba C., Guest S., Haywood S., et al. Chronic hepatitis: a retrospective study in 34 dogs. Can Vet J 38 (1997) 365-373
51. Hoff B., Boermans H.J., and Baird J.D. Retrospective study of toxic metal analyses requested at a veterinary diagnostic toxicology laboratory in Ontario (1990-1995). Can Vet J 39 (1998) 39-43
52. Hyun C., and Filippich L.J. Inherited copper toxicosis in Australian Bedlington terriers. J Vet Sci 5 (2004) 19-28
53. Owen R.A., Haywood S., and Kelly D.F. Clinical course of renal adenocarcinoma associated with hypercupraemia in a horse. Vet Rec 119 (1986) 291-294
54. Teske E., Brinkhuis B.G., Bode P., et al. Cytological detection of copper for the diagnosis of inherited copper toxicosis in Bedlington terriers. Vet Rec 131 (1992) 30-32
55. Twedt D.C., Hunsaker H.A., and Allen K.G. Use of 2,3,2-tetramine as a hepatic copper chelating agent for treatment of copper hepatotoxicosis in Bedlington terriers. J Am Vet Med Assoc 192 (1988) 52-56
56. Andersson M., and Sevelius E. Breed, sex, and age distribution in dogs with chronic liver disease: a demographic study. J Soc Adm Pharm 32 (1991) 1-5
57. Boisclair J., Dore M., Beauchamp G., et al. Characterization of the inflammatory infiltrate in canine chronic hepatitis. Vet Pathol 38 (2001) 628-635
58. K Richter. Common canine hepatopathies. Presented at the 15th American College of Veterinary Internal Medicine forum. San Diego, California 1997.
59. Mandigers P.J., van den Ingh T.S., Bode P., et al. Improvement in liver pathology after 4 months of D-penicillamine in 5 Doberman pinschers with subclinical hepatitis. J Vet Intern Med 19 (2005) 40-43
60. Thornburg L.P., and Crawford S.J. Liver disease in West Highland white terriers. Vet Rec 118 (1986) 110
61. Brewer G.J., Dick R.D., Schall W., et al. Use of zinc acetate to treat copper toxicosis in dogs. J Am Vet Med Assoc 201 (1992) 564-568
62. Hoffmann G., and Rothuizen J. Copper-associated chronic hepatitis. In: Bonagura (Ed). Kirk's current veterinary therapy XIV (2008), Elsevier, St. Louis (MO) 557-562
63. Brewer G.J. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation. J Cell Mol Med 7 (2003) 11-20
64. Brewer GJ. Recognition, diagnosis, and management of Wilson's disease. In: Proceedings of the Society for Experimental Biology and Medicine. 2000. p. 39-46.
65. Roberts E.A., and Schilsky M.L. A practice guideline on Wilsons disease. Hepatology 37 6 (2003) 1475-1492
66. Rolfe D., and Twedt D.C. Copper-associated hepatopathies in dogs. Vet Clin North Am Small Anim Pract 25 (1995) 399-417
67. Klein D., Lichtmannegger J., and Heinzmann U. Dissolution of copper-rich granules in hepatic lysosomes by d-penicillamine prevents the development of fulminant hepatitis in Long-Evans cinnamon rats. J Hepatol 32 (2000) 193-201
68. Munthe E., Jellum E., and Aaseth J. Some aspects of the mechanism of action of penicillamine in rheumatoid arthritis. Scand J Rheumatol Suppl 28 (1979) 6-12
69. Jaffe I. Penicillamine: an anti-rheumatoid drug. Am J Med 75 (1983) 63-68
70. Stanworth D., and Hunneyball I.M. Influence of d-penicillamine treatment on the humoral immune system. Scand J Rheumatol 28 (1979) 37-46
71. Epstein O., De Villiers D., and Jain S. Reduction of immune complexes and immunoglobulins induced by d-penicillamine in primary biliary cirrhosis. N Engl J Med 300 (1979) 274-278
72. Harth M., Keown P.A., and Orange J.F. Effects of d-penicillamine on inflammatory and immune reactions. Clin Invest Med 7 (1984) 45-51
73. Liu N., Lo L.S., Askary S.H., et al. Transcuprein is a macroglobulin regulated by copper and iron availability. J Nutr Biochem 18 (2007) 597-608
74. Montaser A., Tetreault C., and Linder M. Comparison of copper binding components in dog serum with those in other species. Proc Soc Exp Biol Med 200 (1992) 321-329
75. Kuo M.T., Chen H.H., Song I.S., et al. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev 26 (2007) 71-83
76. Fiander H., and Schneider H. Compounds that induce isoforms of glutathione S-transferase with properties of a critical enzyme in defense against oxidative stress. Biochem Biophys Res Commun 262 (1999) 591-595
77. Mosialou E., and Morgenstern R. Activity of rat liver microsomal glutathione transferase toward products of lipid peroxidation and studies of the effect of inhibitors on glutathione-dependent protection against lipid peroxidation. Arch Biochem Biophys 275 (1989) 289-294
78. de Bie P., van de Sluis B., Burstein E., et al. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B. Gastroenterology 133 (2007) 1316-1326
79. de Bie P., Muller P., Wijmenga C., et al. Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J Med Genet 44 (2007) 673-688
80. La Fontaine S., and Mercer J.F. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch Biochem Biophys 463 (2007) 149-167
81. Puig S., Lee J., Lau M., et al. Biochemical and genetic analyses of yeast and human high affinity copper transporters suggest a conserved mechanism for copper uptake. J Biol Chem 277 (2002) 26021-26030
82. Dahlman I., Eaves I.A., Kosoy R., et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 30 (2002) 149-150
83. Kenney S.M., and Cox D.W. Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum Mutat 28 12 (2007) 1171-1177
84. Lutsenko S., and Petris M.J. Function and regulation of the mammalian copper-transporting ATPases: insights from biochemical and cell biological approaches. J Membr Biol 191 (2003) 1-12
85. Lutsenko S., Barnes N.L., Bartee M.Y., et al. Function and regulation of human copper-transporting ATPases. Physiol Rev 87 (2007) 1011-1046
86. Lutsenko S., LeShane E.S., and Shinde U. Biochemical basis of regulation of human copper-transporting ATPases. Arch Biochem Biophys 463 (2007) 134-148
87. Bertini I., and Cavallaro G. Metals in the "omics" world: copper homeostasis and cytochrome c oxidase assembly in a new light. J Biol Inorg Chem 13 1 (2007) 3-14
88. Stasser J.P., Siluvai G.S., Barry A.N., et al. A multinuclear copper(I) cluster forms the dimerization interface in copper-loaded human copper chaperone for superoxide dismutase. Biochemistry 46 (2007) 11845-11856
89. Suazo M., Olivares F., Mendez M.A., et al. CCS and SOD1 mRNA are reduced after copper supplementation in peripheral mononuclear cells of individuals with high serum ceruloplasmin concentration. J Nutr Biochem 19 4 (2007) 269-274
90. Bertinato J., and L'Abbe M.R. Maintaining copper homeostasis: regulation of copper-trafficking proteins in response to copper deficiency or overload. J Nutr Biochem 15 (2004) 316-322
91. Dolderer B., Echner H., Beck A., et al. Coordination of three and four Cu(I) to the alpha- and beta-domain of vertebrate Zn-metallothionein-1, respectively, induces significant structural changes. FEBS J 274 (2007) 2349-2362
92. Formigari A., Irato P., and Santon A. Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp Biochem Physiol C Toxicol Pharmacol 146 (2007) 443-459
93. Burstein E., Hoberg J.E., Wilkinson A.S., et al. COMMD proteins, a novel family of structural and functional homologs of MURR1. J Biol Chem 280 (2005) 22222-22232
94. Maine G.N., and Burstein E. COMMD proteins: COMMing to the scene. Cell Mol Life Sci 64 (2007) 1997-2005
95. van de Sluis A.J.A. Identification of a copper toxicosis gene in Bedlington terriers (2002), University of Utrecht, Utrecht, Netherlands 9-30
96. Burstein E., Ganesh L., Dick R.D., et al. A novel role for XIAP in copper homeostasis through regulation of MURR1. EMBO J 23 (2004) 244-254
97. Tao T.Y., Liu F., Klomp L., et al. The copper toxicosis gene product Murr1 directly interacts with the Wilson disease protein. J Biol Chem 278 (2003) 41593-41596
98. Mufti A.R., Burstein E., Csomos R.A., et al. XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mol Cell 21 (2006) 775-785
99. Lim C.M., Cater M.A., Mercer J.F., et al. Copper-dependent interaction of dynactin subunit p62 with the N terminus of ATP7B but not ATP7A. J Biol Chem 281 (2006) 14006-14014
100. Kelly, et al. Copet toxicosis in Bedlington terriers in the UK. JSAP 25 (1984) 293-298
101. Thornburg L.P. Histomorphical and immunohistochemical studies of chronic active hepatitis in Doberman Pinschers. Vet Pathol 35 5 (1998) 380-385
102. Crawford M.A., Schall W.D., Jensen R.K., et al. Chronic active hepatitis in 26 Doberman pinschers. J Am Vet Med 187 12 (1985) 1343-1350
103. Speeti M., Eriksson J., Saari S., et al. Lesions of subclinical Doberman hepatitis. Vet Pathol 35 5 (1998) 361-369
104. Johnson J.B., Hagstad H.V., and Springer W.T. Chronic active hepatitis in Doberman pinschers. J Am Vet Med Assoc 180 12 (1982) 1438-1442
105. Thornburg, and Rottinghaus. What is the significance of hepatic copper values in dogs with cirrhosis. Vet Med (1985) 50-54
106. Thornburg, et al. High liver copper levels in Doberman pinschers with subacute hepatitis. JAAHA 20 (1983) 1003-1005
107. Napier P. Hepatic necrosis with toxic copper levels in a two-year-old Dalmatian. Can Vet J 37 1 (1996) 45
108. Noaker L.J., Washabau R.J., Detrisiac C.J., et al. Copper associated acute hepatic failure in a dog. J Am Vet Med Assoc 214 10 (1999) 1502-1506
109. Cooper, et al. Hepatitis and increased copper levels in a Dalmatian. J Vet Diagn Invest 9 2 (1997) 201-203
110. McGrotty Y.L., Ramsey I.K., and Knottenbelt C.M. Diagnosis and management of hepatic copper accumulation in a Skye terrier. J Small Anim Pract 44 2 (2003) 85-89
111. Thornburg L.P., Shaw D., Dolan M., Raisbeck M., et al. Hereditary copper toxicosis in West Highland white terriers. Vet Pathol 23 2 (1986) 148-154
112. Brewer G.J., Schall W., Dick R., et al. Use of 64 copper measurements to diagnose canine copper toxicosis. J Vet Intern Med 6 1 (1992) 41-43
113. Thornburg L.P., Rottinghaus G., Dennis G., et al. The relationship between hepatic copper content and morphologic changes in the liver of West Highland White Terriers. Vet Pathol 33 6 (1996) 656-661
114. Shih, et al. Chronic hepatitis in Labrador retrievers: clinical presentation and prognostic factors. J Vet Intern Med 21 (2007) 33-39
115. Thornburg, and Rottinghaus. What is the significance of hepatic copper values in dogs with cirrhosis. Vet Med 80 (1985) 50-54
116. Bosje J.T., Van den Ingh T.S., Fennema A., et al. Copper-induced hepatitis in an Anatolian shepherd dog. Vet Rec 152 3 (2003) 84-85
117. van den Ingh T.S., and Rothuizen J. Accumulation of copper and iron in the liver of a boxer: a new disease?. Tijdschr Diergeneeskd 117 Suppl 1 (1992) 16S
118. Meertens N.M., Bokhove C.A., and van den Ingh T.S. Copper-associated chronic hepatitis and cirrhosis in a European shorthair cat. Vet Pathol 42 1 (2005) 97-100
119. Heynes W. Hepatopathy associated with excessive hepatic copper in a Siamese cat. Vet Pathol 32 (1995) 427-429